Taro Pharmaceutical Industries Ltd (NYSE:TARO)

81.59
Delayed Data
As of Sep 13
 +1.75 / +2.19%
Today’s Change
75.73
Today|||52-Week Range
109.42
-3.60%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$3.1B

Company Description

Taro Pharmaceutical Industries Ltd. is engaged in the development, manufacturing, and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada, and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.

Contact Information

Taro Pharmaceutical Industries Ltd.
14 Hakitor Street
Haifa Bay Haifa 26247
P:(724) 847-5700
Investor Relations:

Employees

Shareholders

Mutual fund holders5.73%
Other institutional5.42%
Individual stakeholders11.76%

Top Executives

Uday Vijaykumar BaldotaChief Executive Officer & Director
Itamar KarsentiVice President & Head-Operations
Mariano BalaguerChief Financial & Accounting Officer, VP
Avi AvramoffGlobal Vice President-Research & Development
Richard GlazeVice President-Information Technology